Viewing Study NCT06205680



Ignite Creation Date: 2024-05-06 @ 7:57 PM
Last Modification Date: 2024-10-26 @ 3:18 PM
Study NCT ID: NCT06205680
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-01-16
First Post: 2023-12-27

Brief Title: Soft Mist Nasal Administration Device for Topical Anaesthesia of the Nasal Cavity
Sponsor: Radboud University Medical Center
Organization: Radboud University Medical Center

Study Overview

Official Title: Soft Mist Nasal Administration Device for Topical Anaesthesia of the Nasal Cavity
Status: NOT_YET_RECRUITING
Status Verified Date: 2023-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Rationale

Effective and fast topical anesthesia of the nasal mucosa is of paramount importance for nasal instrumentation like nasal fiberoptic procedures awake nasal fiberoptic intubation and placement of nasogastric tubes Conventional topical anesthesia for the nasal mucosa is often patchy and not always effective The investigators hypothesize that topical anesthesia of the nasal mucosa with the nasal atomizer adapter NAA provides good to excellent nasal topical anesthesia with high patient comfort

Objective In this study the NAA will be used for nasal topical anesthesia The investigators will evaluate complete anesthesia of the nasal mucosa for nasal instrumentation the use of the NAA and the comfort level for the subjects

Study design Interventional study

Study population 20 healthy human volunteers ASA 1 18-60 years old

Intervention Lidocaine 2 will be applied intranasally with the NAA before nasal instrumentation On completion of the procedure the participant and the researcher will be asked to complete a feedback form

Main study parametersendpoints

Studying the level of anesthesia of the nasal mucosa as evaluated and demonstrated with successful awake nasal instrumentation with minimal discomfort for the subject

Nature and extent of the burden and risks associated with participation

Risk management on the nasal atomizer adapter NAA shows that all user risks are mitigated and no residual risks remain for the use of the device Testing of the device and the application of the device in daily practice has no additional risks than the present technique of performing topical anaesthesia of the nasal mucosa
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None